Product analysis
Vitamin E Complete offers a clearly named natural form of vitamin E at favorable value.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
The declared vitamin E uses a natural form, which is a favorable feature of ingredient quality. The different quantity declarations do not establish a single combined total.
Ingredient Transparency100
The vitamin E amount and form are disclosed. That helps you identify the nutrient and compare the label with other supplements.
Value For Money100
The natural vitamin E offers favorable value for the serving cost. Different declarations should be kept separate when comparing quantities.
Customer Satisfaction87
Customer feedback is very positive across a substantial number of ratings. The broad review base strengthens the satisfaction picture without proving a health benefit.
Product Focus30
The formula stays focused on vitamin E. Its named form and declared serving do not establish a cardiovascular benefit.
- Format
Softgel - Container
- 60 Softgel(s)
- Per serving
- $0.41
- Customer rating
- 4.8 · 2,002 ratings
Goals
Vitamin E Complete lists D-alpha-tocopherol and 200 IU per serving, but the saved facts cannot establish its amount for cardiovascular support. The ingredient is present, while its usable amount remains unknown. No cardiovascular pathway or studied effective amount can be established from these facts.
How this product is rated for Cardiovascular Support
Ingredient fit56
Goal fit
Dose adequacy
Pathways0
Depth
Breadth
Evidence0
Evidence strength
Studied preparation
Formulation logic75
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin E (D-Alpha-Tocopherol) | 200 IU | |
D-Mixed-Tocotrienol | 20 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability68
Natural (d-alpha) vs. Synthetic (dl-alpha)
Mixed Tocopherol Isomer Diversity
Tocotrienol Complex Inclusion
Dose, Safety & Label Transparency85
Therapeutic Dosage Range
Label Transparency and Isomer Specificity
Value100
Cost per Natural-Form Therapeutic Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
- Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
- Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
- Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
- Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
- Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
- Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study.
- Long-term nutrient intake and 5-year change in nuclear lens opacities.
- Dietary intake of antioxidants and risk of age-related macular degeneration.
- Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial.
- Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials.
- Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.
- Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis.
- Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.